Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04293393
Title Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients (CARABELA)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Spanish Breast Cancer Research Group
Indications

Her2-receptor negative breast cancer

Therapies

Cyclophosphamide + Docetaxel + Doxorubicin

Abemaciclib + Letrozole

Abemaciclib + Goserelin + Letrozole

Abemaciclib + Letrozole + Leuprolide

Cyclophosphamide + Doxorubicin + Paclitaxel

Age Groups: senior | adult
Covered Countries


No variant requirements are available.